IRIS
FILICE, GAETANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.222
EU - Europa 2.197
AS - Asia 1.740
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 4
AF - Africa 2
Totale 7.176
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.211
CN - Cina 1.717
IE - Irlanda 759
UA - Ucraina 463
DE - Germania 251
FI - Finlandia 251
SE - Svezia 192
IT - Italia 102
GB - Regno Unito 93
FR - Francia 42
BE - Belgio 19
CA - Canada 11
IN - India 8
NL - Olanda 7
AU - Australia 6
IR - Iran 6
PL - Polonia 6
EU - Europa 4
RU - Federazione Russa 3
CO - Colombia 2
IQ - Iraq 2
MD - Moldavia 2
MU - Mauritius 2
NP - Nepal 2
RO - Romania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
AT - Austria 1
BD - Bangladesh 1
BR - Brasile 1
CH - Svizzera 1
DK - Danimarca 1
ES - Italia 1
HK - Hong Kong 1
IS - Islanda 1
JP - Giappone 1
SG - Singapore 1
TW - Taiwan 1
Totale 7.176
Salva come PNG Salva come JPEG
Città #
Dublin 759
Chandler 740
Jacksonville 560
Nanjing 496
Nanchang 215
Ashburn 188
Beijing 181
Princeton 178
Lawrence 155
Houston 152
Shenyang 143
Changsha 142
Hebei 134
Medford 133
Wilmington 125
Jiaxing 106
Tianjin 89
Ann Arbor 87
Hangzhou 72
Boardman 67
Helsinki 55
New York 49
Shanghai 38
Norwalk 29
Milan 28
Woodbridge 25
Verona 23
Brussels 18
Fairfield 16
Des Moines 13
Pavia 12
Seattle 11
Kunming 10
Ningbo 10
Jinan 9
Los Angeles 9
Zhengzhou 9
Falls Church 8
Orange 8
Toronto 8
Washington 8
Pune 7
Redwood City 7
Taizhou 6
Berlin 5
Guangzhou 5
Lanzhou 5
Sacramento 5
San Francisco 5
Tappahannock 5
Auburn Hills 4
Frankfurt am Main 4
Haikou 4
Poznan 4
Zanjan 4
Andover 3
Borås 3
Chicago 3
Fuzhou 3
Sassari 3
Changchun 2
Chisinau 2
Envigado 2
Jawalakhel 2
Las Vegas 2
Rockville 2
Scuola 2
Senigallia 2
Aarau 1
Amsterdam 1
Bloomfield 1
Bolzano 1
Brescia 1
Brunico 1
Cagliari 1
Canberra 1
Chapel Hill 1
Cuggiono 1
Dallas 1
Dearborn 1
Eindhoven 1
Falkenstein 1
Groningen 1
Hamilton 1
Karby 1
Kashan 1
Kemerovo 1
Latham 1
Leawood 1
Lyon 1
Massapequa 1
Melbourne 1
Monserrato 1
Mountain View 1
Norman 1
Ottawa 1
Philadelphia 1
Pisa 1
Pittsburgh 1
Redmond 1
Totale 5.251
Salva come PNG Salva come JPEG
Nome #
Kinetics of p24 antigenemia, IgM, IgG antibodies to p24 and p41 and Ig virus isolation in rabbits experimentally infected with HIV-1 115
Predictors of bacterial pneumonia in Evaluation of SUbcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT). 111
The Pavia consensus statement 84
The association of "standard ELISA" and HIV (env) ELISA for detection and confirmation of HIV antibodies in human sera 80
Host factors affecting the outcome of treatment of hepatitis C 78
Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection. 78
Mice and rabbits: Animal models for HIV-1 infection 78
In vitro sensitivity of 3 strains of Leptospira interrogans to 3 different antibiotics 74
Effect of teicoplanin and vancomycin on Staphylococcus aureus ultrastructure 73
Life cycle of P. carinii in the lung of immuno-compromised hosts: an ultrastructural study. 73
Aggressive daily interferon therapy in HIV-HCV coinfected patients 72
Booster PCR: evaluation of an improved method for amplification of a few HIV-1 proviral DNA sequences 70
Management of hepatitis C in human immunodeficiency virus-infected patients 69
IgM-IFA, IgM-ELISA, DS-IgM-ELISA, IgM-ISAGA, performed on whole serum and IgM fractions, for detection of IgM anti-toxoplasma antibodies during pregnancy 67
Comments on the review 'Care of patients with hepatitis C and HIV co-infection' by Soriano et al. 67
Rapid hepatitis B virus-DNA decay in co-infected HIV-hepatitis B virus 'eminus' patients with YMDD mutations after 4 weeks of tenofovir therapy 66
Chemotherapy of toxoplasmic encephalitis in AIDS patients 65
Acute liver failure during lamivudine tratment in a hepatitis B cirrhotic patient 64
Could Tenofovir - Modify the Model - End-Stage Liver - Disease (MELD) Score in Patients - With End-Stage Liver Disease Eligible for Liver Transplantation? 63
Malattie Infettive 63
Accuracy of ultrasound imaging technique for assessing lipoatrophy in HIV-infected subjects. 63
Detection of IgG anti-HIV antibodies in mice experimentally infected with HIV-1 62
Hepatotoxicity and nelfinavir: a meta-analysis 62
Distinct mutational drug resistance profiles of HIV-1 RNA in plasma in culture isolates of patients receiving antiretroviral theraphy 62
Forecast model for the evaluation of economic resources employed in the health care of patients with HIV infection. 62
Minimal invasive Treatment for Hydatid Abdominal Cysts: PAIR (Puncture, Aspiration, Injection, Reaspiration)- State of the Art 61
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction. 61
Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study 61
Point shear wave elastography method for assessing liver stiffness. 61
Overview on the incidence and the characteristics of HIV-related opportunistic infections and neoplasms of the heart: impact of highly active antiretroviral therapy 60
Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study. 59
The morphogenesis of BLV (bovine leukemia virus) cultivated on FLK (fetal lamb kidney): an ultrastructural study 58
Influence of genotype 3 hepatitis C coinfection on liver enzyme elevation in HIV-1 positive patients after commencement of a new highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER COHORT 58
Specificity and sensitivity of 3rd generation EIA for detection of HCV antibodies among intravenous drug-users 58
Comparison between IgM-IFA and DS-IgM-ELISA performed on IgM fractions and whole sera in acute acquired toxoplasmosis 57
Clinical experiences with interferon as monotherapy or in combination with ribavirin in patients co-infected with HIV and HCV 57
Entamoebiasi e parassitosi intestinali in un centro di ricovero psichiatrico.Valutazione di efficacia di protocolli di trattamento chemioprofilattico-chemioterapeutico 57
Malattie Infettive 57
Transfusion-transmitted virus infection in HIV-1-seropositive patients 57
A promising cultural-biomolecular method for rapid isolation and identification of mycobacteria 57
A New complement fixation test for toxoplasmosis. Comparison with other serological methods 56
Low rate of virological failure and maintenance of susceptibility to HIV-1 protease inhibitors with first-line lopinavir/ritonavir-based antiretroviral treatment in clinical practice. 56
Recenti Acquisizioni in tema di Diagnosi,terapia e Prevenzione delle Epatiti Acute ad Etiologia Virale. 55
Key questions in antiretroviral therapy: Italian Consensus Workshop (2005) 55
Comparison between the complement fixation test LBCF-H100-TTE, IHAT and IgM-IFAT performed on pure IgM fractions in acute acquired and congenital toxoplasmosis 54
Comparison of the plasma pharmacokinetics of lamivudine during twice and once daily administration in patients with HIV 54
Management of hepatocellular carcinoma in human immunodeficiency virus-infected patients. 54
Endocytosis constitute the infectious route of HIV-1 entry in human and rabbit monocytes lacking the CD4 receptor 54
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. 53
Quantification of HIV-1 proviral DNA in patients with undetectable plasma viremia over long-term highly active antiretroviral therapy 53
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 53
Pathogenesis of liver damage in HCV-HIV patients. 52
Pathogenesis of liver damage in HCV-HIV patients 52
Prevalence and histologic features of transfusion transmitted virus and hepatitis C virus coinfection in a group of HIV patients. 52
Quantitative assessment of cell-associated and cell-free virus in cervicovaginal samples of HIV-1-infected women 51
Epatiti Virali Acute 51
HIV type 1 intraperitoneal infection of rabbits permits early detection of serum antibodies to Gag, Pol, and Env proteins, neutralizing antibodies, and proviral DNA from peripheral blood mononuclear cells 51
Evolution of transmitted HIV-1 drug resistance in HIV-1 infected patients in Italy from 2000 to 2010. 51
Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment 51
Manuale di Virologia Clinica 50
Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilis. 50
Natural history of chronic hepatitis B in co-infected patients. 50
Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure. 50
Controlled attenuation parameter for evaluating liver steatosis in chronic viral hepatitis. 50
Daily Interferon therapy in HIV-HCV coinfected patients: Preliminary Report 50
Viral excretion in the cervicovaginal secretions of HIV-1 infected women receiving antiretroviral therapy. 49
Hepatotoxicity and antiretroviral therapy with protease inhibitors: a review 49
Epatocarcinoma nei soggetti HIV positivi 49
Comparison of peginterferon pharmacokinetic and pharmacodynamic profiles 49
A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen. 49
Pharmacodynamics of peginterferon alpha-2a and peginterferon alpha-2b in interferon-naive patients with chronic hepatitis C: a randomized, controlled study 49
Detection of IgM anti-toxoplasma antibodies in acute acquired and congenital toxoplasmosis 48
Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis: an emerging issue. 48
Human immunodeficiency virus (HIV): an ultrastructural study 48
Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort 47
Tuberculosis meningitis in adults: 5 cases 47
Correlation between FIB4, liver stiffness and metabolic parameters in patients with HIV and hepatitis C virus co-infection. 47
Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naive patients. 47
Daily interferon regimen for chronic hepatitis c. A prospective randomized study. 47
Recent advances in AIDS researches 47
HCV chronic hepatitis in patients with HIV: clinical management issues 47
Mitochondrial toxicity in HIV-HCV coinfection: It depends on the choice of antiretroviral drugs? 46
Rate of CD4+ cell count increase over periods of viral load suppressione: relationship with the number of previous virological failures. 46
Duration of immune protection after hepatitis B vaccine in newborns from HBsAg-positive carrier mothers 46
General issues on microbial translocation in HIV-infected patients 46
Didanosine-ribavirin combination: synergistic combination in vitro, but high potential risk of toxicity in vivo 46
Duration of first-line antiretroviral therapy with enofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort 45
Fast relapse and high drop out rate of 48 weeks daily interferon monotherapy in HIV-infected patients with chronic hepatitis C 45
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 44
Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy 44
Prevalence and histologic features of transfusion transmitted virus and hepatitis C virus coinfection in a group of HIV patients 43
Prevalence of HIV-1 inetgrase mutations related to resistance to dolutegravir in raltegravir naive and pretrated patients. 43
Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI 42
Performance of liver stiffness measurements by transient elastography in chronic hepatitis. 42
Hepatitis B immunization in infants of hepatitis B surface antigen-negative mothers 42
Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study. 41
Sensitivity and specificity of anti-HIV ELISA employing recombinant (p24, p66, gp120) and synthetic (gp41) viral antigenic peptides 41
Arterial stiffness evaluation in HIV-positive patients: a multicenter matched control study. 41
[New trends in the therapy of cryptococcosis in AIDS patients] 41
Fungaemia in hospitalized patients 40
Totale 5.599
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.622
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.622
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201911 0 0 0 0 0 0 0 0 0 0 3 8
2019/20202.172 612 819 2 87 46 204 7 100 8 154 126 7
2020/2021882 102 81 31 89 3 121 10 128 32 128 123 34
2021/2022660 13 5 6 3 12 10 17 42 31 5 112 404
2022/20232.120 244 152 16 173 220 217 0 116 893 9 44 36
2023/2024585 63 126 29 38 72 166 12 54 8 17 0 0
Totale 7.332